Sema3B was initially characterized as a tumor suppressor of lung cancer [99,129,130] and was found to inhibit the progression of additional forms of cancer such as breast cancer, endometrial cancer, osteosarcoma and oral cancer because of the direct effects on the tumor cells [131,132,133]. This evidence concerns the gene SEMA3B and lung carcinoma.